Urinalysis Lab CPRR - Keesler AFB, MS
ID: HT940825R0005Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYSAN ANTONIO, TX, 78230, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Defense, through the Defense Health Agency, is seeking proposals for a Urinalysis Lab system at Keesler Air Force Base in Mississippi. The procurement involves the lease of one urinalysis system with two functioning analyzers, including all necessary equipment, reagents, maintenance, and training for a period of five years, starting from April 2025. This system is critical for conducting approximately 900 UA chemistry tests and 700 microscopic exams monthly, ensuring efficient diagnostic capabilities within the military healthcare system. Interested vendors must submit their proposals by January 2, 2025, and direct any inquiries to Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil.

    Files
    Title
    Posted
    The Medical Device and Equipment Risk Assessment (MDERA), Version 6.4.1, outlines procedures for assessing the cybersecurity compliance of medical devices intended for use by the U.S. Department of Defense (DoD) and the Defense Health Agency (DHA). Vendors must complete a detailed questionnaire to evaluate their devices' readiness before procurement, ensuring alignment with DoD and NIST cybersecurity standards. The document specifies requirements for identifying system characteristics, technical specifications, and operational functionalities while emphasizing the importance of disclosing complete information. Key sections include device identification, system architecture, data processing capabilities, and security measures, such as vulnerability management and encryption protocols. The document requires vendors to provide comprehensive details regarding hardware, software, regulatory certifications, data handling, and connectivity methods. Compliance with these guidelines is critical for obtaining Risk Management Framework (RMF) authorization. Failure to provide accurate information could lead to disqualification from contracts or post-award cancellations. This assessment is vital for maintaining the integrity and security of medical devices within the military healthcare system.
    The document outlines a federal Request for Proposal (RFP) for a Urinalysis Lab Analyzer and related reagents, detailing pricing and service requirements for multiple years. The pricing worksheet includes distinct Contract Line Item Numbers (CLINs) across various contract periods, commencing with a base year and extending through four option years. Each CLIN specifies quantities for UA Chemistry Tests and UA Microscopic Exams, alongside provisions for equipment delivery, installation, maintenance, supplies, and training. The performance period spans from April 2025 to March 2030, indicating ongoing procurement needs in laboratory services and supporting infrastructure. The document emphasizes a structured approach to service delivery and execution regarding urinalysis capabilities, reflecting the government's requirements for quality assurance and compliance through installation and ongoing maintenance. Overall, the RFP signifies the government's commitment to robust health services and laboratory efficiency, ensuring readiness to meet diagnostic needs effectively.
    The document outlines a Request for Proposal (RFP) for the Keesler Medical Center at Keesler Air Force Base, Mississippi, specifically for acquiring a urinalysis (UA) system with dual functioning analyzers under a lease agreement. The selected contractor is required to provide all necessary equipment, maintenance, and reagents for an estimated five-year period, including an initial base year and four one-year options. A total of 900 UA chemistry tests and 700 microscopic exams per month are required, with stipulations for timely service response and technician availability. Key contract terms include the necessity for equipment to be FDA-approved and compatible with the military's laboratory information systems, along with a specific physical installation space. The contractor must ensure that all repairs, training, and preventative maintenance are included without additional costs. Training will also be provided for key personnel. The contracting phase contains essential deadlines, including bid submission by January 2, 2025, and questions submission by December 19, 2024. Compliance with federal procurement regulations is mandatory, reflecting the document's context within government RFPs aimed at enhancing medical operational capacity in military facilities.
    Lifecycle
    Title
    Type
    Similar Opportunities
    6630--Sources Sought - BPA for NCO20 Urinalysis Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20 (NCO20), is seeking qualified vendors to establish a Blanket Purchase Agreement (BPA) for urinalysis testing services across various medical facilities within the Veterans Integrated Service Network (VISN) 20. The procurement aims to secure automated clinical laboratory urinalysis testing, including the provision of necessary equipment, reagents, and maintenance services, with a contract term consisting of a base year plus four option years. This initiative is crucial for ensuring efficient and reliable laboratory services to support the healthcare needs of veterans, with an estimated annual testing volume of approximately 91,740 urine microscopies and 126,410 urine chemistries across multiple locations. Interested vendors, particularly Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB), must submit their capabilities statements and pricing information to Contract Specialist Peter Park at peter.park2@va.gov by January 7, 2025, to be considered for this opportunity.
    Hematology CPRR - Keesler AFB, MS
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for a hematology system to be delivered to the Keesler Medical Center at Keesler Air Force Base in Mississippi. The procurement requires one hematology system that includes two functioning analyzers, a slide maker stainer, and a digital cell morphology system equipped with advanced software for red blood cell morphology. This system is crucial for enhancing patient care and operational capabilities within military healthcare, as it will facilitate the processing of 31,000 complete blood counts over a five-year period. Interested vendors must ensure that their equipment is FDA-approved, meets specific technical specifications, and complies with cybersecurity standards as outlined in the Medical Device and Equipment Risk Assessment. The deadline for proposals has been extended to January 24, 2025, with the period of performance beginning on April 1, 2025. For further inquiries, interested parties can contact Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil.
    Microbiology Lab CPRR - Keesler AFB, MS
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking proposals for the procurement of microbiology laboratory equipment at Keesler Air Force Base in Mississippi. The requirement includes one automated microbial identification system and one automated microbial detection system, along with all necessary equipment, reagents, and maintenance services, to enhance the laboratory's capabilities in microbial testing. This initiative is crucial for improving healthcare services by ensuring accurate and timely microbiology testing, which is essential for patient care. Interested vendors must submit their proposals by January 24, 2025, and can contact Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil for further information.
    Analytical Sample Processing Systems
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA) and the Army Medical Research Acquisition Activity, is seeking information regarding Analytical Sample Processing Systems for the Walter Reed Army Institute of Research (WRAIR). The procurement involves leasing, installation, and validation of pre- and post-analytical specimen processing instrumentation systems, along with preventative and emergency maintenance and necessary consumables. These systems are crucial for ensuring sample integrity and efficient laboratory operations, with a focus on modular design and automated processes. Interested vendors should submit detailed capability statements by December 23, 2024, as the estimated performance period for the systems is from August 2025 to August 2030. For further inquiries, potential respondents can contact Joshua Dean at joshua.r.dean2.civ@health.mil or Jennifer Hayden at jennifer.e.hayden.civ@health.mil.
    REQUEST FOR INFORMATION METABOLOMICS ANALYSIS SERVICES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified vendors for specialized metabolomics analysis services to support ongoing research at the United States Army Medical Research Institute of Environmental Medicine (USARIEM). The procurement aims to obtain both untargeted and targeted metabolomics measurements from various human biological samples, including urine, blood, feces, saliva, and tissue, necessitating advanced laboratory capabilities such as ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). This initiative is critical for enhancing the understanding of metabolic functions and nutritional status within military health studies. Interested parties must submit their qualifications, including business size and capabilities, by January 7, 2025, to Kasey Carroll at kasey.l.carroll.civ@health.mil, as responses are voluntary and will not result in a binding contract.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for pharmaceutical agents to be included in the Uniform Formulary (UF) as part of its pharmacy benefits program for the Military Health System (MHS). This procurement aims to establish Blanket Purchase Agreements (BPAs) and Additional Discount Programs (ADPs) for cost-effective pharmaceutical options, ensuring that the selected agents meet clinical and cost-effectiveness criteria as evaluated by the Pharmacy and Therapeutics (P&T) Committee. The initiative is critical for providing safe and effective medications to military beneficiaries while managing costs within the healthcare system. Interested manufacturers must submit their quotes by December 30, 2024, and can direct inquiries to Tracy Banks or Keith Marasigan via their respective emails for further information.
    RT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS)
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking sources for RT-PCR molecular testing solutions to support the Brooke Army Medical Center’s Department of Pathology and Area Laboratory Services in Fort Cavazos, Texas. The procurement aims to acquire a random-access multiplex testing platform that utilizes FDA-approved reagents and analyzers for various infectious disease tests, including Hepatitis B and C, HIV, and respiratory viruses, thereby enhancing laboratory capabilities and workflow efficiency. This initiative is critical for maintaining high testing standards for military personnel, with a contract period anticipated from October 2025 to September 2026, including three potential extension years. Interested vendors are encouraged to submit capabilities statements by December 30, 2024, and may contact Colleen Rye or Salameya Paulouskaya for further information.
    NHANES General Chemistry Laboratory Testing 2025-2030
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the NHANES General Chemistry Laboratory Testing contract, which will span from February 14, 2025, to February 13, 2030. The primary objective of this procurement is to obtain Clinical Laboratory Improvement Amendments (CLIA) certified laboratory measurements on biological specimens collected through the National Health and Nutrition Examination Survey (NHANES), which aims to provide national statistics on the health and nutritional status of the U.S. population. This contract is crucial for generating national estimates and monitoring trends in chronic diseases, with the contractor responsible for conducting a variety of chemistry tests, including a Comprehensive Metabolic Panel and lipid panels, while ensuring strict confidentiality and compliance with ethical standards. Interested offerors must submit their proposals electronically by the specified deadlines, with a focus on demonstrating technical capabilities and relevant past performance, and can contact David Santimaw at zgm2@cdc.gov or 770-488-5282 for further information.
    Air Force Drug Testing Laboratory (AFDTL) Information Technology (IT) Support Services
    Active
    Dept Of Defense
    The Department of Defense, through the Air Force, is seeking information from qualified businesses to provide Information Technology (IT) Support Services for the Air Force Drug Testing Laboratory (AFDTL) at Joint Base San Antonio, Texas. The objective is to establish a single performance-based contract that encompasses IT support, medical laboratory support, and technical services, aimed at enhancing the AFDTL's mission to deter drug use among military personnel through comprehensive drug testing and the development of detection methodologies. Interested parties are required to submit their company credentials, business size status, relevant experience, and any comments regarding the contract's requirements by January 7, 2025, with responses formatted according to specified guidelines. For further inquiries, interested vendors may contact Jocef Hernandez at jocef.hernandez.2@us.af.mil or Theresa Jackson at theresa.jackson.5@us.af.mil.